股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2026年1月31日 | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | 公司名稱: | 江南布衣有限公司 | | | | | 呈交日期: | 2026年2月2日 | | | | | I. 法定/註冊股本變動 | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) 是 | | 證券代號 (如上市) | 03306 | 說明 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | 上月底結存 | | | 1,000,000,000 | HKD | 0.01 | HKD | 10,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | 0 | | 本月底結存 | | | 1,000, ...

江南布衣(03306)发布公告，按照日期为2026年1月23日的配售协议，于2026年1月30日发行的新股份 1453.5万股。 ...

Group 1 - The company Jiangnan Buyi (03306) announced the issuance of new shares totaling 14.535 million shares on January 30, 2026, according to a placement agreement dated January 23, 2026 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | | 是 | | | | 證券代號 (如上市) 03306 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | | 每股發行/出售價 (註4) | | 已發行股份總數 | | 於下列日期開始時的結存(註1) 2025年12月31日 | | 518,750,000 | | | 0 | | | 518,750,000 | | 1). 配售/認購 - 涉及新股 | | 14 ...

Core Viewpoint - Jiangnan Buyi (03306) has successfully completed a placement of shares as per the terms of the placement agreement dated January 23, 2026, with no major shareholders being created as a result of this placement [1] Group 1: Placement Details - A total of 14.535 million shares were successfully placed at a price of HKD 18.78 per share [1] - This placement represents approximately 2.80% of the total issued shares as of the placement agreement date [1] - Following the completion of the placement, the enlarged total issued shares will reflect approximately 2.73% [1]

配售事项所得款项总额约为272.97百万港元，而所得款项净额约为269.99百万港元。公司拟按照下列方 式动用所得款项净额：(i)约40%或108.00百万港元将用于加强品牌业务发展；(ii)约50%或135.00百万港 元将用于研发投资以进一步提升综合市场竞争力；及(iii)约10%或27.00百万港元将用作一般及企业用 途。公司估计将于2026年12月前悉数动用上述配售事项所得款项净额。 合共1453.5万股配售股份已由配售代理根据配售协议的条款及条件按每股配售股份18.78港元的配售价向 不少于六名承配人成功配售，相当于：(a)于配售协议日期已发行股份总数的约2.80%；及(b)紧随配售事 项完成后经扩大已发行股份总数的约2.73%。 格隆汇1月30日丨江南布衣(03306.HK)布，日期为2026年1月23日的配售协议所载之所有条件已获达成且 配售事项已于2026年1月30日按照配售协议的条款及条件完成。据公司所知，概无承配人及其最终实益 拥有人将因配售事项而成为主要股东。 ...

Core Viewpoint - Jiangnan Buyi (03306) has successfully completed a placement of 14.535 million shares at a price of HKD 18.78 per share, with no major shareholders emerging from the placement [1] Group 1: Placement Details - The placement agreement conditions were fulfilled, and the placement was completed on January 30, 2026 [1] - A total of 14.535 million shares were placed, representing approximately 2.80% of the total shares issued as of the placement agreement date [1] - Following the completion of the placement, the newly issued shares represent about 2.73% of the enlarged total shares [1]

本公告僅供參考，並不構成收購、購買或認購本公司任何證券的邀請或要約。 本公告並不構成在美國購買或認購證券的任何要約或招攬或其一部分。本公告所述 證券並未且將不會根據一九三三年美國證券法（「美國證券法」）進行登記，亦不會在 美國提呈發售或出售，除非根據美國證券法作出登記或獲豁免或為毋須根據美國證 券法作出登記之交易。本公司無意根據美國證券法登記本公告內所指之任何證券， 或在美國進行證券之公開發售。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 本公告或其任何副本概不得直接或間接在美國，或在刊發或派發本公告屬違法的任 何其他司法權區內刊發或派發。 （於開曼群島註冊成立的有限公司） JNBY Design Limited （股份代號：3306） 江南布衣有限公司 完成根據一般授權 配售新股份 整體協調人、配售代理及資本市場中介人 完成配售新股份 董事會欣然宣佈，日期為二零二六年一月二十三日的配售協議（「配售協議」）所載之 所有條件已獲達成且配售事項已於二 ...

Group 1 - CMB International maintains a "Buy" rating for Anta Sports with a target price of HKD 108.70, noting a low single-digit decline in Q4 revenue for the Anta brand, while FILA and other brands show resilience with a growth of 35%-40% [1] - CMB International also maintains a "Buy" rating for China Resources Beverage with a target price of HKD 11.87, indicating that 2025 will be a year of pressure release, with stable market share in packaged water and potential improvements in sales incentives [1] Group 2 - CMB International maintains a "Buy" rating for Hutchison China MediTech, highlighting the significant superiority of Savolitinib combination therapy over chemotherapy in MET amplified NSCLC, with global sales peak potential exceeding USD 1.8 billion [2] - CMB International maintains a "Buy" rating for China Resources Power with a target price of HKD 21.05, projecting a 6.7% increase in core profit for 2025, with a 9.8% decrease in thermal coal fuel costs partially offsetting coal price rebounds [3] Group 3 - CITIC Securities maintains a "Buy" rating for Geek+, setting a target price of HKD 53.00, with a significant upward revision of order growth from 30% to 40% for 2026, and successful penetration into North American key accounts [4] - CITIC Securities maintains a "Buy" rating for Jiangnan Buyi, noting excellent performance in FY1H26 and a fundraising of HKD 270 million to enhance brand development, with expected high single-digit to double-digit growth in revenue and profit [5] Group 4 - CITIC Securities maintains a "Buy" rating for Xaircraft with a target price of HKD 87.00, emphasizing its leading position in general aviation and private aviation, with current valuations not reflecting its brand potential and scarcity [6] - CITIC Jiantou maintains a "Buy" rating for Xtep International, indicating flat revenue for the main brand in Q4 2025, with bright performance in running categories and successful adjustments in e-commerce [7][8]

友邦保险-R(81299)、京东健康-R(86618)、百度集团-SWR(89888)上一交易日沽空比率位于前三位，分别 为100.00%、100.00%、95.46%。泡泡玛特(09992)、阿里巴巴-W(09988)、小米集团-W(01810)的沽空金 额位居前三，分别为13.00 亿元、12.60 亿元、10.64 亿元。百度集团-SWR(89888)、深圳高速公路股份 (00548)、商汤-WR(80020)的偏离值位居前三，分别为62.11%、37.02%、34.65%。 前十大沽空比率排行 前十大沽空偏离值排行 | 股票名称 | 沽空金额 | 沽空比率 | 偏离值↓ | | --- | --- | --- | --- | | 百度集团-SWR(89888) | 119.43 万元 | 95.46% | 62.11% | | 深圳高速公路股份(00548) | 164.67 万元 | 48.73% | 37.02% | | 商汤-WR(80020) | 15.48 万元 | 87.41% | 34.65% | | 中国平安-R(82318) | 245.20 万元 | 72.58% | 33.06% ...